Cancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.

by Kevin McLaughlin

Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

by Marci A. Landsmann

The executive editor of Cancer Today previews the new issue.

by Kevin McLaughlin

When visiting a friend or family member who is sick, it's good to leave platitudes at the door.

by Michael Gavaghen

A study suggests that 3-D mammograms may reduce unnecessary biopsies, and the U.S. Food and Drug Administration issues warnings to breast implant companies.

by Kate Yandell

NCI director steps in as FDA commissioner, new guidelines on clinical trial eligibility, and health risks for childhood cancer survivors.

by Bradley Jones

Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.

by Anna Azvolinsky

FDA Commissioner Scott Gottlieb resigns, an analysis explores patient advocacy groups' financial ties, and Alex Trebek announces he has pancreatic cancer.

by Marci A. Landsmann

Patients diagnosed with low-risk prostate cancer are increasingly opting against immediate surgery or radiation in favor of regularly monitoring their disease.

by Jon Kelvey

A blood test for tumor mutations shows promise as an option for lung cancer patients, and the U.S. Food and Drug Administration expresses concern about robotically-assisted cancer surgery.

by Kate Yandell